Reader TTS

ABSTRACT Veno-occlusive disease is among the most serious complications following hematopoietic stem cell transplantation. While hepatic veno-occlusive disease occurs more commonly, the

pulmonary variant remains quite rare and often goes unrecognized antemortem. Endothelial damage may represent the pathophysiologic foundation of these clinical syndromes. Recent advances in

the treatment of hepatic veno-occlusive disease may have application to its pulmonary counterpart. Access through your institution Buy or subscribe This is a preview of subscription content,

access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn

more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS

OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS ENDOTHELIAL CELL DYSFUNCTION: A KEY DETERMINANT

FOR THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION Article Open access 12 July 2021 MANAGEMENT OF LIVER SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE IN ADULTS: A 2025

PERSPECTIVE FROM AN INTERNATIONAL EXPERT GROUP Article 22 April 2025 DIFFUSE ALVEOLAR HEMORRHAGE: AN UNDERREPORTED COMPLICATION OF TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY Article 28

March 2022 REFERENCES * Appelbaum FR . Hematopoietic-cell transplantation at 50. _N Engl J Med_ 2004; 357: 1472–1475. Article  Google Scholar  * Copelan EA . Hematopoietic stem-cell

transplantation. _N Engl J Med_ 2006; 354: 1813–1826. Article  CAS  PubMed  Google Scholar  * Woywodt A, Haubitz M, Buchholz S, Hertenstein B . Counting the cost: markers of endothelial

damage in hematopoietic stem cell transplantation. _Bone Marrow Transplant_ 2004; 34: 1015–1023. Article  CAS  PubMed  Google Scholar  * Villalon L, Avello AG, Cesar J, Odriozola J, Lopez J,

Oteyza JP _et al_. Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)? _Thromb Res_

2000; 99: 439–446. Article  CAS  PubMed  Google Scholar  * Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M _et al_. Risk factors and severe outcome in thrombotic

microangiopathy after allogeneic hematopoietic stem cell transplantation. _Transplantation_ 2006; 82: 638–644. Article  PubMed  Google Scholar  * Matute-Bello G, McDonald GD, Hinds MS,

Schoch HG, Crawford SW . Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation. _Bone Marrow Transplant_ 1998;

21: 1125–1130. Article  CAS  PubMed  Google Scholar  * Cooke KR, Yanik G . Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host

disease? _Bone Marrow Transplant_ 2004; 34: 753–765. Article  CAS  PubMed  Google Scholar  * Gordon B, Lyden E, Lynch J, Tarantolo S, Pavletic ZS, Bishop M _et al_. Central nervous system

dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients. _Bone Marrow Transplant_ 2000; 25: 79–83. Article  CAS  PubMed  Google Scholar

  * Haire WD . Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation. _Crit Care Med_ 2002; 30 (5 Suppl): S257–S262. Article  PubMed  Google Scholar  * Troussard X,

Bernaudin JF, Cordonnier C, Fleury J, Payen D, Briere J _et al_. Pulmonary veno-occlusive disease after bone marrow transplantation. _Thorax_ 1984; 39: 956–957. Article  CAS  PubMed  PubMed

Central  Google Scholar  * Hackman RC, Madtes DK, Petersen FB, Clark JG . Pulmonary venoocclusive disease following bone marrow transplantation. _Transplantation_ 1989; 47: 989–992. Article

  CAS  PubMed  Google Scholar  * Williams LM, Fussell S, Veith RW, Nelson S, Mason CM . Pulmonary veno-occlusive disease in an adult following bone marrow transplantation. Case report and

review of the literature. _Chest_ 1996; 109: 1388–1391. Article  CAS  PubMed  Google Scholar  * Seguchi M, Hirabayashi N, Fujii Y, Azuno Y, Fujita N, Takeda K _et al_. Pulmonary hypertension

associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. _Transplantation_ 2000; 69: 177–179. Article  CAS  PubMed  Google Scholar  * Trobaugh-Lotrario

AD, Greffe B, Deterding R, Deutsch G, Quinones R . Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: case report and

literature review. _J Pediatr Hematol Oncol_ 2003; 25: 405–409. Article  PubMed  Google Scholar  * Mukai M, Kondo M, Bohgaki T, Notoya A, Kohno M . Pulmonary veno-occlusive disease following

allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia. _Br J Haematol_ 2003; 123: 1. Article  PubMed  Google Scholar  * Mandel J, Mark EJ, Hales CA . Pulmonary

veno-occlusive disease. _Am J Respir Crit Care Med_ 2000; 162: 1964–1973. Article  CAS  PubMed  Google Scholar  * Kuga T, Kohda K, Hirayama Y, Matsumoto S, Nakazawa O, Ando M _et al_.

Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia. _Int J Hematol_ 1996;

64: 143–150. Article  CAS  PubMed  Google Scholar  * Salzman D, Adkins DR, Craig F, Freytes C, LeMaistre CF . Malignancy-associated pulmonary veno-occlusive disease: report of a case

following autologous bone marrow transplantation and review. _Bone Marrow Transplant_ 1996; 18: 755–760. CAS  PubMed  Google Scholar  * Or R, Nagler A, Elad S, Naparstek E, Schechter D .

Noncardiogenic pulmonary congestion following bone marrow transplantation. _Respiration_ 1997; 64: 170–172. Article  CAS  PubMed  Google Scholar  * Holcomb BW, Loyd JE, Ely EW, Johnson J,

Robbins IM . Pulmonary veno-occlusive disease: a case series and new observations. _Chest_ 2000; 118: 1671–1679. PubMed  Google Scholar  * Veeraraghavan S, Koss MN, Sharma OP . Pulmonary

veno-occlusive disease. _Curr Opin Pulm Med_ 1999; 5: 310–313. Article  CAS  PubMed  Google Scholar  * Lantuejoul S, Sheppard MN, Corrin B, Burke MM, Nicholson AG . Pulmonary veno-occlusive

disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. _Am J Surg Pathol_ 2006; 30: 850–857. Article  PubMed  Google Scholar  * Hora J . Zur histologie der

klinischen ‘primaren Pulmonalsklerose’. _Frankf Z Pathol_ 1934; 47: 100. Google Scholar  * Heath D, Segel N, Bishop J . Pulmonary veno-occlusive disease. _Circulation_ 1966; 34: 242–248.

Article  CAS  PubMed  Google Scholar  * Nunes H, Humbert M, Capron F, Brauner M, Sitbon O, Battesti JP _et al_. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics

and prognosis. _Thorax_ 2006; 61: 68–74. Article  CAS  PubMed  Google Scholar  * Johnson SR, Patsios D, Hwang DM, Granton JT . Pulmonary veno-occlusive disease and scleroderma associated

pulmonary hypertension. _J Rheumatol_ 2006; 33: 2347–2350. PubMed  Google Scholar  * Zhang L, Visscher D, Rihal C, Aubry MC . Pulmonary veno-occlusive disease as a primary cause of pulmonary

hypertension in a patient with mixed connective tissue disease. _Rheumatol Int_ 2007; 27: 1163–1165. Article  PubMed  Google Scholar  * Shahab N, Haider S, Doll DC . Vascular toxicity of

antineoplastic agents. _Semin Oncol_ 2006; 33: 121–138. Article  CAS  PubMed  Google Scholar  * Saito A, Takizawa H, Ito K, Yamamoto K, Oka T . A case of pulmonary veno-occlusive disease

associated with systemic sclerosis. _Respirology_ 2003; 8: 383–385. Article  PubMed  Google Scholar  * Voordes CG, Kuipers JR, Elema JD . Familial pulmonary veno-occlusive disease: a case

report. _Thorax_ 1977; 32: 763–766. Article  CAS  PubMed  PubMed Central  Google Scholar  * Davies P, Reid L . Pulmonary veno-occlusive disease in siblings: case reports and morphometric

study. _Hum Pathol_ 1982; 13: 911–915. Article  CAS  PubMed  Google Scholar  * Runo JR, Vnencak-Jones CL, Prince M, Loyd JE, Wheeler L, Robbins IM _et al_. Pulmonary veno-occlusive disease

caused by an inherited mutation in bone morphogenetic protein receptor II. _Am J Respir Crit Care Med_ 2003; 167: 889–894. Article  PubMed  Google Scholar  * Kufe DW, Frei III E, Holland JF,

Weichselbaum RR, Pollock RE, Bast RC _et al_. _Holland-Frei Cancer Medicine_, 7th edn. BC Decker Inc.: Columbia, 2006. Google Scholar  * Takatsuka H, Wakae T, Mori A, Okada M, Okamoto T,

Kakishita E . Effects of total body irradiation on the vascular endothelium. _Clin Transplant_ 2002; 16: 374–377. Article  PubMed  Google Scholar  * Soubani AO, Miller KB, Hassoun PM .

Pulmonary complications of bone marrow transplantation. _Chest_ 1996; 109: 1066–1077. Article  CAS  PubMed  Google Scholar  * Kotloff RM, Ahya VN, Crawford SW . Pulmonary complications of

solid organ and hematopoietic stem cell transplantation. _Am J Respir Crit Care Med_ 2004; 170: 22–48. Article  PubMed  Google Scholar  * Roychowdhury M, Pambuccian SE, Aslan DL, Jessurun J,

Rose AG, Manivel JC _et al_. Pulmonary complications after bone marrow transplantation: an autopsy study from a large transplantation center. _Arch Pathol Lab Med_ 2005; 129: 366–371.

Article  PubMed  Google Scholar  * Camus P, Costabel U . Drug-induced respiratory disease in patients with hematological diseases. _Semin Respir Crit Care Med_ 2005; 26: 458–481. Article 

PubMed  Google Scholar  * Wagenvoort CA, Wagenvoort N, Takahashi T . Pulmonary veno-occlusive disease: involvement of pulmonary arteries and review of the literature. _Hum Pathol_ 1985; 16:

1033–1041. Article  CAS  PubMed  Google Scholar  * Malhotra P, Varma S, Varma N, Sharma RR, Jain S, Kumari S _et al_. Pulmonary veno-occlusive disease as a cause for reversible pulmonary

hypertension in a patient with multiple myeloma undergoing peripheral blood stem cell transplantation. _Am J Hematol_ 2005; 80: 164–165. Article  PubMed  Google Scholar  * Frazier AA, Franks

TJ, Mohammed TL, Ozbudak IH, Galvin JR . From the archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. _Radiographics_ 2007; 27: 867–882. Article

  PubMed  Google Scholar  * Ware LB, Matthay MA . The acute respiratory distress syndrome. _N Engl J Med_ 2000; 342: 1334–1349. Article  CAS  PubMed  Google Scholar  * Rambihar VS, Fallen

EL, Cairns JA . Pulmonary veno-occlusive disease: antemortem diagnosis from roentgenographic and hemodynamic findings. _Can Med Assoc J_ 1979; 120: 1519–1522. CAS  PubMed  PubMed Central 

Google Scholar  * Weed HG . Pulmonary ‘capillary’ wedge pressure not the pressure in the pulmonary capillaries. _Chest_ 1991; 100: 1138–1140. Article  CAS  PubMed  Google Scholar  * Almagro

P, Alvarez M, Garau J . Lung biopsy in pulmonary veno-occlusive disease. _Chest_ 2001; 120: 1421–1422. Article  CAS  PubMed  Google Scholar  * Drexler H, Hornig B . Endothelial dysfunction

in human disease. _J Mol Cell Cardiol_ 1999; 31: 51–60. Article  CAS  PubMed  Google Scholar  * Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP _et al_. Endothelial cells

in physiology and in the pathophysiology of vascular disorders. _Blood_ 1998; 91: 3527–3561. CAS  PubMed  Google Scholar  * Catani L, Gugliotta L, Vianelli N, Nocentini F, Baravelli S,

Bandini G _et al_. Endothelium and bone marrow transplantation. _Bone Marrow Transplant_ 1996; 17: 277–280. CAS  PubMed  Google Scholar  * Testa S, Manna A, Porcellini A, Maffi F,

Morstabilini G, Denti N _et al_. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation. _Bone

Marrow Transplant_ 1996; 18: 383–388. CAS  PubMed  Google Scholar  * Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D _et al_. Treatment of severe veno-occlusive

disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. _Blood_ 1998; 92: 737–744. CAS  PubMed  Google Scholar  * Chopra R,

Eaton JD, Grassi A, Potter M, Shaw B, Salat C _et al_. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. _Br J Haematol_ 2000;

111: 1122–1129. CAS  PubMed  Google Scholar  * Salat C, Holler E, Kolb HJ, Reinhardt B, Pihusch R, Wilmanns W _et al_. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic

veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. _Blood_ 1997; 89: 2184–2188. Article  CAS  PubMed  Google Scholar  * Richardson PG, Hoppensteadt

D, Elias AD, Frei E, Iacobelli M, Guinan E _et al_. Elevation of tissue factor pathway inhibitor (TFPI), thrombomodulin (TM), and plasminogen activator inhibitor-1 (PAI-1) levels in stem

cell transplant associated veno-occlusive disease and changes with the use of defibrotide. _Blood_ 1997; 90: 219a. Google Scholar  * Richardson PG, Krishnan A, Wheeler C, Hoppensteadt D,

Tuchin J, Fyfe H _et al_. Elevation of PAI-1 levels in BMT associated VOD and changes seen in the use of Defibrotide. _Blood_ 1996; 88: 458a. Google Scholar  * Lahm T, Crisostomo PR, Markel

TA, Wang M, Lillemoe KD, Meldrum DR . The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. _Shock_ 2007; 28: 4–14. Article  CAS  PubMed

  Google Scholar  * Iguchi A, Kobayashi R, Yoshida M, Kobayashi K, Matsuo K, Kitajima I _et al_. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of

hepatic veno-occlusive disease (VOD) in stem cell transplantation. _Bone Marrow Transplant_ 2001; 27: 1173–1180. Article  CAS  PubMed  Google Scholar  * Barst RJ . PDGF signaling in

pulmonary arterial hypertension. _J Clin Invest_ 2005; 115: 2691–2694. Article  CAS  PubMed  PubMed Central  Google Scholar  * Assaad AM, Kawut SM, Arcasoy SM, Rosenzweig EB, Wilt JS, Sonett

JR _et al_. Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis. _Chest_ 2007; 131: 850–855. Article  PubMed  Google Scholar  * McDonald GB, Hinds MS, Fisher

LD, Schoch HG, Wolford JL, Banaji M _et al_. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. _Ann Intern Med_

1993; 118: 255–267. Article  CAS  PubMed  Google Scholar  * Wadleigh M, Ho V, Momtaz P, Richardson P . Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. _Curr Opin

Hematol_ 2003; 10: 451–462. Article  PubMed  Google Scholar  * Kumar S, DeLeve LD, Kamath PS, Tefferi A . Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic

stem cell transplantation. _Mayo Clin Proc_ 2003; 78: 589–598. Article  PubMed  Google Scholar  * Kalayoglu-Besisik S, Yenerel MN, Caliskan Y, Ozturk S, Besisik F, Sargin D . Time-related

changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years. _Transplant Proc_

2005; 37: 2285–2289. Article  CAS  PubMed  Google Scholar  * Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G _et al_. A prospective survey on incidence, risk factors and

therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. _Haematologica_ 2005; 90: 1396–1404. PubMed  Google Scholar  * Falanga A, Vignoli A,

Marchetti M, Barbui T . Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells. _Leukemia_ 2003; 17: 1636–1642. Article  CAS  PubMed  Google

Scholar  * Kuroki I, Miyazaki T, Mizukami I, Matsumoto N, Matsumoto I . Effect of sodium nitroprusside on ischemia-reperfusion injuries of the rat liver. _Hepatogastroenterology_ 2004; 51:

1404–1407. CAS  PubMed  Google Scholar  * Kaleelrahman M, Eaton JD, Leeming D, Bowyer K, Taberner D, Chang J _et al_. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the

diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF). _Hematology_ 2003; 8: 91–95. Article  CAS  PubMed  Google Scholar  *

Izbicki G, Shitrit D, Schechtman I, Bendayan D, Fink G, Sahar G _et al_. Recurrence of pulmonary veno-occlusive disease after heart-lung transplantation. _J Heart Lung Transplant_ 2005; 24:

635–637. Article  PubMed  Google Scholar  * Liu C, Chen J . Endothelin receptor antagonists for pulmonary arterial hypertension. _Cochrane Database Systematic Reviews_ 2005; Issue 1, Art

No.: CD004434 (doi:10.1002/14651858.CD004434.pub3). * Hoeper MM, Eschenbruch C, Zink-Wohlfart C, Schulz A, Markworth S, Pohl K _et al_. Effects of inhaled nitric oxide and aerosolized

iloprost in pulmonary veno-occlusive disease. _Respir Med_ 1999; 93: 62–64. Article  CAS  PubMed  Google Scholar  * Palevsky HI, Pietra GG, Fishman AP . Pulmonary veno-occlusive disease and

its response to vasodilator agents. _Am Rev Respir Dis_ 1990; 142: 426–429. Article  CAS  PubMed  Google Scholar  * Kuroda T, Hirota H, Masaki M, Sugiyama S, Oshima Y, Terai K _et al_.

Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease. _Heart Lung Circ_ 2006; 15: 139–142. Article  PubMed  Google Scholar  * Palmer SM,

Robinson LJ, Wang A, Gossage JR, Bashore T, Tapson VF . Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. _Chest_ 1998; 113:

237–240. Article  CAS  PubMed  Google Scholar  * Okumura H, Nagaya N, Kyotani S, Sakamaki F, Nakanishi N, Fukuhara S _et al_. Effects of continuous IV prostacyclin in a patient with

pulmonary veno-occlusive disease. _Chest_ 2002; 122: 1096–1098. Article  PubMed  Google Scholar  * Salzman GA, Rosa UW . Prolonged survival in pulmonary veno-occlusive disease treated with

nifedipine. _Chest_ 1989; 95: 1154–1156. Article  CAS  PubMed  Google Scholar  * Gilroy Jr RJ, Teague MW, Loyd JE . Pulmonary veno-occlusive disease. Fatal progression of pulmonary

hypertension despite steroid-induced remission of interstitial pneumonitis. _Am Rev Respir Dis_ 1991; 143 (5 Part 1): 1130–1133. Article  PubMed  Google Scholar  * Johnson SR, Granton JT,

Mehta S . Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. _Chest_ 2006; 130: 545–552. Article  CAS  PubMed  Google Scholar  * Eissner G, Iacobelli M, Bluml S, Burger

V, Haffner S, Andreesen R _et al_. Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity. _Bone

Marrow Transplant_ 2005; 35: 915–920. Article  CAS  PubMed  Google Scholar  * Haussmann U, Fischer J, Eber S, Scherer F, Seger R, Gungor T . Hepatic veno-occlusive disease in pediatric stem

cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy. _Haematologica_ 2006; 91: 795–800. PubMed  Google Scholar  *

Ringden O, Remberger M, Lehmann S, Hentschke P, Mattsson J, Klaesson S _et al_. N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation. _Bone Marrow

Transplant_ 2000; 25: 993–996. Article  CAS  PubMed  Google Scholar  * Bearman SI . Avoiding hepatic veno-occlusive disease: what do we know and where are we going? _Bone Marrow Transplant_

2001; 27: 1113–1120. Article  CAS  PubMed  Google Scholar  * Kelly GS . Clinical applications of N-acetylcysteine. _Altern Med Rev_ 1998; 3: 114–127. CAS  PubMed  Google Scholar  * Raunio H,

Hakkola J, Hukkanen J, Lassila A, Paivarinta K, Pelkonen O _et al_. Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue. _Exp Toxicol Pathol_ 1999; 51: 412–417. Article 

CAS  PubMed  Google Scholar  * Kehrer JP . Bleomycin and cyclophosphamide toxicity in mice with damaged lung tissue. _Toxicology_ 1989; 57: 69–82. Article  CAS  PubMed  Google Scholar 

Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Medicine, University of Minnesota, Minneapolis, MN, USA M C Bunte, M M Patnaik, M R Pritzker & L J Burns *

Division of Cardiology, University of Minnesota, Minneapolis, MN, USA M R Pritzker * Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA L J

Burns Authors * M C Bunte View author publications You can also search for this author inPubMed Google Scholar * M M Patnaik View author publications You can also search for this author

inPubMed Google Scholar * M R Pritzker View author publications You can also search for this author inPubMed Google Scholar * L J Burns View author publications You can also search for this

author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to L J Burns. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Bunte, M., Patnaik, M.,

Pritzker, M. _et al._ Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction. _Bone Marrow Transplant_ 41, 677–686

(2008). https://doi.org/10.1038/sj.bmt.1705990 Download citation * Received: 06 December 2007 * Accepted: 06 December 2007 * Published: 28 January 2008 * Issue Date: April 2008 * DOI:

https://doi.org/10.1038/sj.bmt.1705990 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not

currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * pulmonary veno-occlusive disease * endothelial

dysfunction * hematopoietic stem cell transplant * defibrotide